Skip to main content
. 2022 Apr 6;14(4):797. doi: 10.3390/pharmaceutics14040797

Figure 1.

Figure 1

Schematic illustration of active tumor-targeted drug NCs that penetrate BBB and BBTB, and target glioma in vivo. BBB, blood-brain barrier; BBTB, blood-brain tumor barrier; NCs, nanocrystals; RBC, red blood cell; RBC-NCs, red blood cell membrane-coated drug nanocrystals.